Related Experiment Video
Updated: Jun 8, 2026
12:44
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
[Phyllodes tumors and breast sarcomas: a review]
J Grenier1, C Delbaldo, L Zelek
1Institut Sainte-Catherine, chemin du Lavarin, BP 846, 84082, Avignon cedex 02, France. j.grenier@isc84.org
Bulletin Du Cancer
|September 22, 2010
Summary
Phyllodes tumors and breast sarcomas are rare non-epithelial breast cancers. Treatment and prognosis depend on tumor type, grade, and surgical approach, with surgery being the primary intervention for both.
Area of Science:
- Oncology
- Pathology
Context:
- Phyllodes tumors and sarcomas are rare non-epithelial breast neoplasms.
- Distinguishing phyllodes tumors from fibroadenomas can be challenging.
- Breast sarcomas are exceptionally rare, with various histological subtypes.
Purpose:
- To outline the characteristics, diagnostic challenges, prognostic factors, and treatment strategies for phyllodes tumors and breast sarcomas.
- To highlight the differences in management and prognosis between these two tumor types.
Summary:
- Phyllodes tumors range from benign to malignant, with prognosis influenced by histology, surgery, and stromal proliferation. Treatment involves surgery, with radiotherapy for high-grade tumors.
- Breast sarcomas have variable histology, with grade, margins, and necrosis as key prognostic factors. Angiosarcoma presents a high risk of recurrence and metastases.
- Mastectomy is standard for sarcomas, though conservative treatment may be considered. Radiotherapy is used for larger or high-grade tumors. Chemotherapy is reserved for high-risk cases.
Impact:
- Provides a comprehensive overview for clinicians managing rare breast tumors.
- Aids in understanding the prognostic indicators and treatment nuances for phyllodes tumors and sarcomas.
- Informs therapeutic decisions, emphasizing the importance of tailored treatment strategies based on tumor characteristics.
